Study Of The Long Term Outcome Of Tuberculous Meningitis In Vietnamese Adults Treated With Adjunctive Dexamethasone
NCT01317654 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 340
Last updated 2011-09-15
Summary
All patients who were alive at the end of the dexamethasone treatment trial conducted by Oxford University CLinical Research Unit from 2001-2005 (n=340) will be eligible to participate in this long-term follow-up study.
All eligible and consenting patients will undergo an assesment consisting of a simple questionnaire, a clinical examination and a blood test. Data collected will focus on survival, neurological disability and tuberculosis relapse. Data will be collected in individual case record forms and entered into a computer database.
Conditions
- Tuberculosis Meningitis
Interventions
- OTHER
-
Observation
Collection of mortality data at 5 years post trial
Sponsors & Collaborators
-
Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam
collaborator OTHER -
Pham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam
collaborator OTHER -
Oxford University Clinical Research Unit, Vietnam
lead OTHER
Principal Investigators
-
Estee Torok, MD · Oxford University Clinical Research Unit - Viet Nam
Eligibility
- Min Age
- 1 Year
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-04-30
- Primary Completion
- 2008-04-30
- Completion
- 2008-04-30
More Related Trials
-
A Study to Assess the Safety of Adacel® Vaccine
NCT01040052 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine
NCT00514059 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Anti-Tetanus Toxin Monoclonal Antibody Injection
NCT07149454 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years
NCT01529645 ·Status: COMPLETED ·Phase: PHASE1
-
Studies of In Vitro B Lymphocyte Responses in Subjects Receiving Tetanus Toxoid Booster Immunization
NCT00001173 ·Status: COMPLETED
-
3-year Follow-up After a Single Dose Acellular Pertussis Vaccination
NCT04102137 ·Status: COMPLETED
-
Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age
NCT01346293 ·Status: COMPLETED ·Phase: PHASE3
-
5-year Follow-up After a Single Dose Acellular Pertussis Vaccination
NCT04529720 ·Status: COMPLETED
-
Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine
NCT06184542 ·Status: RECRUITING ·Phase: PHASE1
-
TBE (Tick-borne Encephalitis) Vaccination in Allergic Patients
NCT02511535 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients
NCT00715234 ·Status: COMPLETED ·Phase: NA
-
Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®
NCT00355121 ·Status: COMPLETED ·Phase: PHASE2
-
Understanding Typhoid Disease After Vaccination
NCT01405521 ·Status: COMPLETED ·Phase: PHASE2
-
2-year Follow-up After a Single Dose Acellular Pertussis Vaccination
NCT04113655 ·Status: COMPLETED
-
Immunogenicity and Safety of a Tetanus-diphtheria Vaccine and a 13-valent Pneumococcal Conjugate Vaccine
NCT03552445 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity of a Combined Diphtheria-Tetanus-recombinant Acellular Pertussis (DTaP) Vaccine in Healthy Toddlers
NCT07213089 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Tdap Vaccine Safety for Plasma Donors
NCT04142983 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Tdap Vaccine in Post-Partum Women
NCT01711645 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
NCT02587520 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Immunogenicity Study for Use of Menactra® Versus Adacel® in Subjects 11 to 55 Years of Age in South Korea
NCT01642589 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
NCT01311557 ·Status: COMPLETED ·Phase: PHASE4
-
Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects
NCT02992418 ·Status: TERMINATED ·Phase: PHASE3
-
Database Surveillance Safety Study of PENTACEL® Vaccine
NCT00804284 ·Status: COMPLETED
-
Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose
NCT01439165 ·Status: COMPLETED ·Phase: PHASE4
-
Persistency Study After aP / Tdap Booster Vaccines in Adult Subjects (V113_01 Extension 1)
NCT02382913 ·Status: COMPLETED ·Phase: PHASE1